Yahoo · Oct 6, 2026
Fortitude Doubles Down on Zcash Mining With $100M BITMAIN Commitment
Fortitude Mining Holdings signed a non-binding letter of intent with Bitmain Technologies, according to a Monday
NASDAQ · HSCSW
Healthcare · Medical - Devices
$0.07
Up+$0.00 (+0.15%)
Updated Oct 11, 2026, 3:38 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HSCSW
1M range · 10 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
HSCSW closed at $0.07 after 10 trading sessions, up 17.99% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $0.07 | $0.07 | $0.0681 | $0.0681 | 906 |
| Oct 8, 2026 | $0.0681 | $0.0681 | $0.068 | $0.068 | 9.84K |
| Oct 6, 2026 | $0.0995 | $0.0998 | $0.06 | $0.06 | 8.61K |
| Oct 5, 2026 | $0.0997 | $0.0997 | $0.0995 | $0.0995 | 12.55K |
| Oct 1, 2026 | $0.046 | $0.046 | $0.0459 | $0.0459 | 8.51K |
| Sep 22, 2026 | $0.0525 | $0.0549 | $0.0437 | $0.0437 | 5.37K |
| Sep 18, 2026 | $0.051 | $0.0538 | $0.0435 | $0.0537 | 26.57K |
| Sep 17, 2026 | $0.07 | $0.0949 | $0.0429 | $0.0429 | 32.81K |
| Sep 16, 2026 | $0.07 | $0.07 | $0.0503 | $0.06 | 3.38K |
| Sep 14, 2026 | $0.0599 | $0.06 | $0.0508 | $0.0577 | 2.91K |
The latest Smart Investors Daily articles mentioning HSCSW.
Company
Market Activity
Research & News


The latest Smart Investors Daily articles mentioning HSCSW.
No results
No recent SID articles mention HSCSW.
HSCSW research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
2 matching articles.
Yahoo · Oct 6, 2026
Fortitude Mining Holdings signed a non-binding letter of intent with Bitmain Technologies, according to a Monday
Yahoo · Oct 6, 2026
Southlake, TX, Oct. 06, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted 510(k) clearance (K260005) for its MyoVista® wavECGTM device as a 12-lead resting electrocardiograph. The clearance covers the